[1]
Maycock NJ, Jayaswal R. Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes. Cornea. 2016 May:35(5):713-20. doi: 10.1097/ICO.0000000000000804. Epub
[PubMed PMID: 26989955]
[2]
Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD. Amoebic infection of the eye. Lancet (London, England). 1974 Dec 28:2(7896):1537-40
[PubMed PMID: 4140981]
[3]
Verani JR, Lorick SA, Yoder JS, Beach MJ, Braden CR, Roberts JM, Conover CS, Chen S, McConnell KA, Chang DC, Park BJ, Jones DB, Visvesvara GS, Roy SL, AcanthamoebaKeratitis Investigation Team. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerging infectious diseases. 2009 Aug:15(8):1236-42. doi: 10.3201/eid1508.090225. Epub
[PubMed PMID: 19751585]
[4]
Smirnov AV, Chao E, Nassonova ES, Cavalier-Smith T. A revised classification of naked lobose amoebae (Amoebozoa: lobosa). Protist. 2011 Oct:162(4):545-70. doi: 10.1016/j.protis.2011.04.004. Epub 2011 Jul 28
[PubMed PMID: 21798804]
[5]
Clarke DW, Niederkorn JY. The pathophysiology of Acanthamoeba keratitis. Trends in parasitology. 2006 Apr:22(4):175-80
[PubMed PMID: 16500148]
[6]
Kong HH. Molecular phylogeny of acanthamoeba. The Korean journal of parasitology. 2009 Oct:47 Suppl(Suppl):S21-8. doi: 10.3347/kjp.2009.47.S.S21. Epub
[PubMed PMID: 19885332]
[7]
Booton GC, Visvesvara GS, Byers TJ, Kelly DJ, Fuerst PA. Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. Journal of clinical microbiology. 2005 Apr:43(4):1689-93
[PubMed PMID: 15814986]
[8]
Szentmáry N, Daas L, Shi L, Laurik KL, Lepper S, Milioti G, Seitz B. Acanthamoeba keratitis - Clinical signs, differential diagnosis and treatment. Journal of current ophthalmology. 2019 Mar:31(1):16-23. doi: 10.1016/j.joco.2018.09.008. Epub 2018 Oct 19
[PubMed PMID: 30899841]
[9]
Siddiqui R, Khan NA. Biology and pathogenesis of Acanthamoeba. Parasites & vectors. 2012 Jan 10:5():6. doi: 10.1186/1756-3305-5-6. Epub 2012 Jan 10
[PubMed PMID: 22229971]
[10]
Biddick CJ, Rogers LH, Brown TJ. Viability of pathogenic and nonpathogenic free-living amoebae in long-term storage at a range of temperatures. Applied and environmental microbiology. 1984 Oct:48(4):859-60
[PubMed PMID: 6508294]
[11]
Randag AC, van Rooij J, van Goor AT, Verkerk S, Wisse RPL, Saelens IEY, Stoutenbeek R, van Dooren BTH, Cheng YYY, Eggink CA. The rising incidence of Acanthamoeba keratitis: A 7-year nationwide survey and clinical assessment of risk factors and functional outcomes. PloS one. 2019:14(9):e0222092. doi: 10.1371/journal.pone.0222092. Epub 2019 Sep 6
[PubMed PMID: 31491000]
Level 3 (low-level) evidence
[12]
Acharya NR, Lietman TM, Margolis TP. Parasites on the rise: a new epidemic of Acanthamoeba keratitis. American journal of ophthalmology. 2007 Aug:144(2):292-3
[PubMed PMID: 17659960]
[13]
Ibrahim YW, Boase DL, Cree IA. Factors affecting the epidemiology of Acanthamoeba keratitis. Ophthalmic epidemiology. 2007 Mar-Apr:14(2):53-60
[PubMed PMID: 17464851]
[14]
Juárez MM, Tártara LI, Cid AG, Real JP, Bermúdez JM, Rajal VB, Palma SD. Acanthamoeba in the eye, can the parasite hide even more? Latest developments on the disease. Contact lens & anterior eye : the journal of the British Contact Lens Association. 2018 Jun:41(3):245-251. doi: 10.1016/j.clae.2017.12.017. Epub 2017 Dec 19
[PubMed PMID: 29273391]
[15]
Zanetti S, Fiori PL, Pinna A, Usai S, Carta F, Fadda G. Susceptibility of Acanthamoeba castellanii to contact lens disinfecting solutions. Antimicrobial agents and chemotherapy. 1995 Jul:39(7):1596-8
[PubMed PMID: 7492111]
[16]
Shoff ME, Joslin CE, Tu EY, Kubatko L, Fuerst PA. Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates. Cornea. 2008 Jul:27(6):713-9. doi: 10.1097/QAI.0b013e31815e7251. Epub
[PubMed PMID: 18580265]
[17]
Johnston SP, Sriram R, Qvarnstrom Y, Roy S, Verani J, Yoder J, Lorick S, Roberts J, Beach MJ, Visvesvara G. Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions. Journal of clinical microbiology. 2009 Jul:47(7):2040-5. doi: 10.1128/JCM.00575-09. Epub 2009 Apr 29
[PubMed PMID: 19403771]
[18]
Garg P, Kalra P, Joseph J. Non-contact lens related Acanthamoeba keratitis. Indian journal of ophthalmology. 2017 Nov:65(11):1079-1086. doi: 10.4103/ijo.IJO_826_17. Epub
[PubMed PMID: 29133630]
[19]
Jiang C, Sun X, Wang Z, Zhang Y. Acanthamoeba keratitis: clinical characteristics and management. The ocular surface. 2015 Apr:13(2):164-8. doi: 10.1016/j.jtos.2015.01.002. Epub 2015 Jan 29
[PubMed PMID: 25881999]
[20]
Bunsuwansakul C, Mahboob T, Hounkong K, Laohaprapanon S, Chitapornpan S, Jawjit S, Yasiri A, Barusrux S, Bunluepuech K, Sawangjaroen N, Salibay CC, Kaewjai C, Pereira ML, Nissapatorn V. Acanthamoeba in Southeast Asia - Overview and Challenges. The Korean journal of parasitology. 2019 Aug:57(4):341-357. doi: 10.3347/kjp.2019.57.4.341. Epub 2019 Aug 31
[PubMed PMID: 31533401]
Level 3 (low-level) evidence
[21]
Kim JH, Matin A, Shin HJ, Park H, Yoo KT, Yuan XZ, Kim KS, Jung SY. Functional roles of mannose-binding protein in the adhesion, cytotoxicity and phagocytosis of Acanthamoeba castellanii. Experimental parasitology. 2012 Oct:132(2):287-92. doi: 10.1016/j.exppara.2012.08.007. Epub 2012 Aug 24
[PubMed PMID: 22940016]
[22]
Hong YC, Lee WM, Kong HH, Jeong HJ, Chung DI. Molecular cloning and characterization of a cDNA encoding a laminin-binding protein (AhLBP) from Acanthamoeba healyi. Experimental parasitology. 2004 Mar-Apr:106(3-4):95-102
[PubMed PMID: 15172216]
[23]
Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite (Paris, France). 2015:22():10. doi: 10.1051/parasite/2015010. Epub 2015 Feb 18
[PubMed PMID: 25687209]
[24]
Hadas E, Mazur T. Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ). 1993 Sep:44(3):197-200
[PubMed PMID: 8256097]
[25]
Cao Z, Jefferson DM, Panjwani N. Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba. The Journal of biological chemistry. 1998 Jun 19:273(25):15838-45
[PubMed PMID: 9624184]
[26]
Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. The British journal of ophthalmology. 1995 Dec:79(12):1078-82
[PubMed PMID: 8562539]
[27]
Wilhelmus KR, Jones DB, Matoba AY, Hamill MB, Pflugfelder SC, Weikert MP. Bilateral acanthamoeba keratitis. American journal of ophthalmology. 2008 Feb:145(2):193-197. doi: 10.1016/j.ajo.2007.09.037. Epub
[PubMed PMID: 18222188]
[28]
Alkharashi M, Lindsley K, Law HA, Sikder S. Medical interventions for acanthamoeba keratitis. The Cochrane database of systematic reviews. 2015 Feb 24:2015(2):CD010792. doi: 10.1002/14651858.CD010792.pub2. Epub 2015 Feb 24
[PubMed PMID: 25710134]
Level 1 (high-level) evidence
[29]
Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. American journal of ophthalmology. 2009 Oct:148(4):487-499.e2. doi: 10.1016/j.ajo.2009.06.009. Epub 2009 Aug 5
[PubMed PMID: 19660733]
[30]
Wang Y, Feng X, Jiang L. Current advances in diagnostic methods of Acanthamoeba keratitis. Chinese medical journal. 2014:127(17):3165-70
[PubMed PMID: 25189964]
Level 3 (low-level) evidence
[31]
Wang YE, Tepelus TC, Vickers LA, Baghdasaryan E, Gui W, Huang P, Irvine JA, Sadda S, Hsu HY, Lee OL. Role of in vivo confocal microscopy in the diagnosis of infectious keratitis. International ophthalmology. 2019 Dec:39(12):2865-2874. doi: 10.1007/s10792-019-01134-4. Epub 2019 Jun 17
[PubMed PMID: 31209694]
[32]
Karsenti N, Lau R, Purssell A, Chong-Kit A, Cunanan M, Gasgas J, Tian J, Wang A, Ralevski F, Boggild AK. Development and validation of a real-time PCR assay for the detection of clinical acanthamoebae. BMC research notes. 2017 Jul 28:10(1):355. doi: 10.1186/s13104-017-2666-x. Epub 2017 Jul 28
[PubMed PMID: 28754142]
Level 1 (high-level) evidence
[33]
Patel SP, Schaefer JL, Jaber R, Paterson J, Liu W, Gonzalez-Fernandez F. The Value of Cytology Smears for Acanthamoeba Keratitis. Case reports in ophthalmological medicine. 2016:2016():4148968. doi: 10.1155/2016/4148968. Epub 2016 Jun 15
[PubMed PMID: 27403362]
Level 3 (low-level) evidence
[34]
El-Sayed NM, Hikal WM. Several staining techniques to enhance the visibility of Acanthamoeba cysts. Parasitology research. 2015 Mar:114(3):823-30. doi: 10.1007/s00436-014-4190-4. Epub 2014 Oct 28
[PubMed PMID: 25346196]
[35]
Grossniklaus HE, Waring GO 4th, Akor C, Castellano-Sanchez AA, Bennett K. Evaluation of hematoxylin and eosin and special stains for the detection of acanthamoeba keratitis in penetrating keratoplasties. American journal of ophthalmology. 2003 Sep:136(3):520-6
[PubMed PMID: 12967807]
[36]
Mathers WD, Sutphin JE, Folberg R, Meier PA, Wenzel RP, Elgin RG. Outbreak of keratitis presumed to be caused by Acanthamoeba. American journal of ophthalmology. 1996 Feb:121(2):129-42
[PubMed PMID: 8623882]
[37]
Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. The Journal of antimicrobial chemotherapy. 2012 Nov:67(11):2576-97. doi: 10.1093/jac/dks275. Epub 2012 Jul 24
[PubMed PMID: 22833634]
[38]
Papa V, Rama P, Radford C, Minassian DC, Dart JKG. Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases. The British journal of ophthalmology. 2020 Apr:104(4):575-581. doi: 10.1136/bjophthalmol-2019-314485. Epub 2019 Aug 10
[PubMed PMID: 31401556]
Level 3 (low-level) evidence
[39]
Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group. The British journal of ophthalmology. 1998 Dec:82(12):1387-92
[PubMed PMID: 9930269]
Level 3 (low-level) evidence
[40]
Marchenko NR, Kasparova EA. [Treatment of Acanthamoeba keratitis]. Vestnik oftalmologii. 2016:132(5):110-116. doi: 10.17116/oftalma20161325110-116. Epub
[PubMed PMID: 28635735]
[41]
Tavassoli S, Buckle M, Tole D, Chiodini P, Darcy K. The use of miltefosine in the management of refractory Acanthamoeba keratitis. Contact lens & anterior eye : the journal of the British Contact Lens Association. 2018 Aug:41(4):400-402. doi: 10.1016/j.clae.2018.03.007. Epub 2018 Mar 24
[PubMed PMID: 29580956]
[42]
Dewan N, Ming W, Holland SP, Yeung SN, Iovieno A. Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis. Cornea. 2019 Jul:38(7):914-917. doi: 10.1097/ICO.0000000000001968. Epub
[PubMed PMID: 31170106]
[43]
Iovieno A, Miller D, Ledee DR, Alfonso EC. Cysticidal activity of antifungals against different genotypes of Acanthamoeba. Antimicrobial agents and chemotherapy. 2014 Sep:58(9):5626-8. doi: 10.1128/AAC.02635-14. Epub 2014 Jul 7
[PubMed PMID: 25001304]
[44]
Tu EY, Joslin CE, Shoff ME. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy. Cornea. 2010 Sep:29(9):1066-8. doi: 10.1097/ICO.0b013e3181cbfa2c. Epub
[PubMed PMID: 20539217]
[45]
Sunada A, Kimura K, Nishi I, Toyokawa M, Ueda A, Sakata T, Suzuki T, Inoue Y, Ohashi Y, Asari S, Iwatani Y. In vitro evaluations of topical agents to treat Acanthamoeba keratitis. Ophthalmology. 2014 Oct:121(10):2059-65. doi: 10.1016/j.ophtha.2014.04.013. Epub 2014 May 29
[PubMed PMID: 24880905]
[46]
Klüppel M, Reinhard T, Sundmacher R, Daicker B. [Therapy of advanced amoeba keratitis with keratoplasty à chaud and adjuvant cryotherapy]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 1997 Feb:94(2):99-103
[PubMed PMID: 9156647]
[47]
Seitz B, Resch MD, Schlötzer-Schrehardt U, Hofmann-Rummelt C, Sauer R, Kruse FE. Histopathology and ultrastructure of human corneas after amniotic membrane transplantation. Archives of ophthalmology (Chicago, Ill. : 1960). 2006 Oct:124(10):1487-90
[PubMed PMID: 17030720]
[48]
Szentmáry N, Goebels S, Bischoff M, Seitz B. [Photodynamic therapy for infectious keratitis]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2012 Feb:109(2):165-70. doi: 10.1007/s00347-011-2511-x. Epub
[PubMed PMID: 22350551]
[49]
Kandori M, Inoue T, Shimabukuro M, Hayashi H, Hori Y, Maeda N, Tano Y. Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy. Cornea. 2010 Oct:29(10):1199-202. doi: 10.1097/ICO.0b013e3181d3d674. Epub
[PubMed PMID: 20595894]
Level 3 (low-level) evidence
[50]
Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology. 2011 Feb:118(2):324-31. doi: 10.1016/j.ophtha.2010.06.041. Epub 2010 Sep 29
[PubMed PMID: 20884060]
Level 3 (low-level) evidence
[51]
Anwar A, Siddiqui R, Raza Shah M, Khan NA. Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba castellanii. Journal of microbiology and biotechnology. 2019 May 28:29(5):713-720. doi: 10.4014/jmb/1903.03009. Epub
[PubMed PMID: 31030451]
[52]
Gomart G, Denis J, Bourcier T, Dory A, Abou-Bacar A, Candolfi E, Sauer A. In Vitro Amoebicidal Activity of Titanium Dioxide/UV-A Combination Against Acanthamoeba. Investigative ophthalmology & visual science. 2018 Sep 4:59(11):4567-4571. doi: 10.1167/iovs.18-25003. Epub
[PubMed PMID: 30242357]
[53]
Daas L, Szentmáry N, Eppig T, Langenbucher A, Hasenfus A, Roth M, Saeger M, Nölle B, Lippmann B, Böhringer D, Reinhard T, Kelbsch C, Messmer E, Pleyer U, Roters S, Zhivov A, Engelmann K, Schrecker J, Zumhagen L, Thieme H, Darawsha R, Meyer-Ter-Vehn T, Dick B, Görsch I, Hermel M, Kohlhaas M, Seitz B. [The German Acanthamoeba keratitis register: Initial results of a multicenter study]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2015 Sep:112(9):752-63. doi: 10.1007/s00347-014-3225-7. Epub
[PubMed PMID: 25833754]
Level 2 (mid-level) evidence
[54]
Mascarenhas J, Lalitha P, Prajna NV, Srinivasan M, Das M, D'Silva SS, Oldenburg CE, Borkar DS, Esterberg EJ, Lietman TM, Keenan JD. Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features. American journal of ophthalmology. 2014 Jan:157(1):56-62. doi: 10.1016/j.ajo.2013.08.032. Epub 2013 Nov 5
[PubMed PMID: 24200232]
[55]
Raghavan A, Baidwal S, Vijayaraghavan P, Rajeswari S, Rajaraman R, Venkatapathy N, Menon S, Rammohan R. Diagnostic Evaluation of Co-Occurrence of Acanthamoeba and Fungi in Keratitis: A Preliminary Report. Cornea. 2018 Feb:37(2):227-234. doi: 10.1097/ICO.0000000000001441. Epub
[PubMed PMID: 29111995]
[56]
Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P. Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology. 1993 Aug:100(8):1238-43
[PubMed PMID: 8341508]
[57]
Carnt N, Stapleton F. Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists). 2016 Mar:36(2):77-92. doi: 10.1111/opo.12271. Epub 2015 Dec 21
[PubMed PMID: 26691018]